Intuitive Surgical Inc. (ISRG) Stock Analysis 2026

Intuitive Surgical is the undisputed leader in robotic-assisted surgery, with its da Vinci surgical system installed in 9,000+ hospitals worldwide. The company's robots assist surgeons in performing minimally invasive procedures across urology (prostatectomy), gynecology (hysterectomy), general surgery (hernia repair, cholecystectomy), and thoracic surgery. Intuitive launched the next-generation da Vinci 5 system in 2024, its most significant platform upgrade in a decade.

This chart shows how Intuitive Surgical's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Intuitive Surgical Inc. trades at a trailing P/E of 42.01x, generates $2.62B in free cash flow, runs a debt/equity ratio of 0.95, and converts shareholder equity into profit at a 17.4% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

28 analysts covering Intuitive Surgical Inc. currently lean toward a Buy rating, with a mean 12-month price target of $478.01 (+21.5% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

We use 1 valuation model to estimate ISRG's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

ISRG is currently in a short-term uptrend, trading above its 50-day average of $383.61 and below its 200-day average of $467.59. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

ISRG's investment case breaks down into 4 bull points and 4 bear points below. The bull case outlines the key reasons the stock could outperform — competitive advantages, growth catalysts, and market tailwinds. The bear case highlights the most significant risks. A strong bull case with manageable bear risks typically makes for a more compelling investment.